Sponsor:
Astellas Pharma Global Development, Inc.
Code:
NCT02960022
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
enzalutamide
abiraterone acetate
prednisone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-10. This information was provided to ClinicalTrials.gov by Astellas Pharma Global Development, Inc. on 2025-05-22.